| Tretinoin | Approved Investigational Nutraceutical | CCDC88A | 55704 |
downregulated | Tretinoin results in decreased expression of CCDC88A mRNA | 2p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC88C | 440193 |
downregulated | Tretinoin results in decreased expression of CCDC88C mRNA | 14q32.11-q32.12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC9 | 26093 |
downregulated | Tretinoin results in decreased expression of CCDC9 mRNA | 19q13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC90B | 60492 |
upregulated | Tretinoin results in increased expression of CCDC90B mRNA | 11q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC93 | 54520 |
downregulated | Tretinoin results in decreased expression of CCDC93 mRNA | 2q14.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCDC96 | 257236 |
upregulated | Tretinoin results in increased expression of CCDC96 mRNA | 4p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL1 | 6346 |
upregulated | Tretinoin results in increased expression of CCL1 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL2 | 6347 |
downregulated | Tretinoin results in decreased expression of CCL2 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL2 | 6347 |
upregulated | Tretinoin results in increased expression of CCL2 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL20 | 6364 |
upregulated | Tretinoin results in increased expression of CCL20 mRNA | 2q36.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL22 | 6367 |
upregulated | Tretinoin results in increased expression of CCL22 mRNA | 16q21 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL24 | 6369 |
upregulated | Tretinoin results in increased expression of CCL24 mRNA | 7q11.23 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL3 | 6348 |
upregulated | Tretinoin results in increased expression of CCL3 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL4 | 6351 |
upregulated | Tretinoin results in increased expression of CCL4 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL5 | 6352 |
upregulated | Tretinoin results in increased expression of CCL5 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCL7 | 6354 |
upregulated | Tretinoin results in increased expression of CCL7 mRNA | 17q12 | |
| Tretinoin | Approved Investigational Nutraceutical | CCM2 | 83605 |
upregulated | Tretinoin results in increased expression of CCM2 mRNA | 7p13 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNA1 | 8900 |
downregulated | Tretinoin results in decreased expression of CCNA1 mRNA | 13q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNA2 | 890 |
downregulated | Tretinoin results in decreased expression of CCNA2 mRNA | 4q27 | |
| Tretinoin | Approved Investigational Nutraceutical | CCNB2 | 9133 |
downregulated | Tretinoin results in decreased expression of CCNB2 mRNA | 15q22.2 | |
| Tretinoin | Approved Investigational Nutraceutical | CCND1 | 595 |
downregulated | Tretinoin results in decreased expression of CCND1 mRNA | 11q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCND1 | 595 |
upregulated | Tretinoin results in increased expression of CCND1 mRNA | 11q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | CCND2 | 894 |
upregulated | Tretinoin results in increased expression of CCND2 mRNA | 12p13.32 | |
| Tretinoin | Approved Investigational Nutraceutical | CCND3 | 896 |
downregulated | Tretinoin results in decreased expression of CCND3 mRNA | 6p21.1 | |
| Tretinoin | Approved Investigational Nutraceutical | CCND3 | 896 |
upregulated | Tretinoin results in increased expression of CCND3 mRNA | 6p21.1 | |